Future Price to Earnings: thejoint.com (JYNT)

Corporate emblem and logo of The Joint (JYNT)

The Joint Corp. (JYNT) has limited ability to manage membership costs due to patients' disposable income, although the subscription model provides certain pricing flexibility. The business is based on providing medical services and creating therapy products. This market valuation chart for The Joint Corp. (JYNT) demonstrates a value of 21.20, complementing data on the chiropractic network's development through partnerships with private practitioners to expand audience reach.

The Joint Corp - JYNT Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/12/2026)
Brand item of The Joint

This metric adjusts for reporting lags by comparing the current quote with expected annual earnings. This ratio determines the market value of a unit of future profit, neutralizing inflationary distortions. For The Joint Corp. (JYNT), the calculation reflects the capitalization of a scalable franchising network without insurance encumbrances. The growth in the company's expected price-to-earnings ratio confirms investor confidence in the expansion of affordable therapy. Peak values of the indicator signal a risk of overpaying for the asset.

Direct competitors

Forward P/E Multiple HCA|THC - Projected Price to Earnings Ratio|Future Price to Earnings Fresenius Medical Care Corp FMS|SOLV: Price to Future Earnings Ratio|EHC: Projected Price to Earnings|Universal Health Services - Market Cap to Future Earnings Ratio|DVA (DaVita) - Projected Price to Earnings|RDNT: Market Cap to Future Earnings Ratio|OPCH (Option Care Health Inc) - Forward P/E Multiple|SGRY: Future Price to Earnings Multiple|Forward P/E Multiple PINC|EYE - Projected Price to Earnings Ratio|Progyny - Projected Price to Earnings|Future Price to Earnings Multiple ARDT|SEM - Future Price to Earnings|Astrana Corp - Market Cap to Future Earnings Ratio|mednax.com (MD) - Future Price to Earnings|Projected Price to Earnings Ratio U.S. Physical Therapy, Inc. (USPH)|PNTG (The Pennant Group) - Forward P/E Multiple|Organogenesis Holdings Inc. (ORGO) - Market Cap to Projected Earnings|Future Price to Earnings Nutex Health Corp (NUTX)|Auna Corp - Price to Future Earnings Ratio|SBC Medical Group Holdings Inc - Projected Price to Earnings|Market Cap to Future Earnings Ratio EOLS (evolus.com)|CYH: Projected Price to Earnings|Future Price to Earnings Multiple SKIN (The Beauty Health)|MDWD: Forward P/E Multiple|Projected Price to Earnings Biote Corporation|Future Price to Earnings DocGo Inc.|Projected Price to Earnings Ratio P3 Health PIII|Future Price to Earnings Gain Therapeutics (GANX)|EUDA (EUDA Health Holdings) - Future Price to Earnings Multiple|Future Price to Earnings Basel Medical Group Ltd BMGL|CLGN (CollPlant) - Price to Expected Earnings Ratio|CUPR: Projected Price to Earnings|Market Cap to Projected Earnings concordmedical.com CCM|American Shared Hospital Services (AMS) - Future Price to Earnings|MRM: Market Cap to Future Earnings Ratio|Projected Price to Earnings ALBT|Projected Price to Earnings Ratio DIH Group DHAI|Future Price to Earnings Longevity Health Holdings (XAGE)|newgenivf.com - Price to Future Earnings Ratio|ATI Physical Therapy, Inc. - Projected Price to Earnings|Market Cap to Future Earnings Ratio CMAX (CareMax Inc.)|KDLY: Projected Price to Earnings|ModivCare Corp - Market Cap to Future Earnings Ratio|Novo Integrated Sciences (NVOS) - Future Price to Earnings|SunLink Health Systems, Inc. - Future Price to Earnings Multiple|BACK (IMAC Holdings) - Forward P/E Multiple